INKKI peptide
General Information
DRACP ID DRACP01103
Peptide Name INKKI peptide
Sequence INKKI
Sequence Length 5
UniProt ID Not available
PubChem CID Not available
Origin β-Casein
Type Native peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=3.78 µg/mL | MTT assay | 24h | 1 |
MDA-MB-231 | Breast adenocarcinoma | Carcinoma | IC50=3.53 μg/mL | MTT assay | 24h | 1 |
T-47D | Invasive breast carcinoma of no special type | Carcinoma | IC50=3.26 μg/mL | MTT assay | 24h | 1 |
MCF-7 | Invasive breast carcinoma of no special type | Carcinoma | IC50=3.07 μg/mL | MTT assay | 24h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Fibroblast FN-1 (human): no effect (testing time is 24 h); Endothelial CRL 1730 (human) : no effect (testing time is 24 h)
Target Not available
Affinity Not available
Mechanism By apoptosis via mitochondrial pathway in a caspase-independent manner
Nature Anticancer; Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C28H54N8O7
Absent amino acids ACDEFGHLMPQRSTVWY
Common amino acids IK
Mass 68632
Pl 10.81
Basic residues 2
Acidic residues 0
Hydrophobic residues 2
Net charge 2
Boman Index -790
Hydrophobicity -46
Aliphatic Index 156
Half Life
Mammalian:
Yeast:
E.coli:
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 1
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Evaluation of the antitumor and antiproliferative effects of the INKKI peptide on MCF-7 breast adenocarcinoma cells
Doi Not available
Year 2020
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available